Skip to content

Author

Wei-Ming Zhao

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Metabolic Reprogramming at the Tumor–Immune Interface in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) arises predominantly in chronic liver disease with a uniquely tolerogenic microenvironment. Immune checkpoint inhibitors (ICIs) have improved the prognosis of advanced HCC, yet most patients exhibit low response rates or therapeutic resistance due to the highly immunosuppressive tumor mic...

Wei-Ming Zhao, Ping Li · 0 citations
Open access Aug 2026

Integrative TWAS and multi-omics analyses prioritize HSPE1 as a candidate risk gene for bipolar disorder with immune cell–specific regulatory evidence

This integrative multi-omics study identified HSPE1 as a candidate BD risk gene with immune-cell-related regulatory evidence, providing insight into BD pathogenesis and supporting functional validation.

Peng Shen, Hao-Hao Xu, Yan Zhou et al. · 0 citations
Review Open access 2026

Research progress of EGFR-TKI resistance mechanism and treatment strategy in non-small cell lung cancer.

A hierarchical logical relationship of heterogeneous EGFR-TKI resistance mechanisms is clarified to provide evidence-based references for individualized post-resistance clinical decision-making, and offer feasible directions for subsequent translational research and therapeutic optimization.

Yujia Zhai, Xilong Zhou, Wei-Ming Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.